LIMODAY-2.5
MRP: 3,600
Packaging: 20X1X5
Pack Type: tablet
Composition:
Letrozole 2.5mg
Indication:
For successful ovulation in, Unexplained infertility, PCOS, CC non responders.
Description:
Letrozole 2.5mg is a prescription medication used primarily to treat hormone receptor-positive breast cancer in postmenopausal women. It belongs to the class of aromatase inhibitors, which work by reducing estrogen production in the body. By lowering estrogen levels, Letrozole helps slow or stop the growth of certain types of breast tumors that require estrogen to grow. It is also sometimes prescribed off-label to induce ovulation in women with fertility issues.
Tags:
- Effectively reduces estrogen levels in hormone-sensitive breast cancer
- Helps control tumor growth and recurrence risk
- Supports ovulation induction for women with infertility
- Oral medication with convenient dosing
Usage Information
Dosage
Breast Cancer: Usually 2.5mg once daily as prescribed by an oncologist. Fertility: Taken on specific cycle days as advised by a fertility specialist. Take with or without food at the same time each day.
Side Effects
Hot flashes and sweating Joint or muscle pain Fatigue and weakness Dizziness or headache Nausea or gastrointestinal upset Bone thinning or osteoporosis (long-term use)
Contraindications
Pregnancy and breastfeeding Premenopausal women unless under specialist care Allergy to Letrozole or aromatase inhibitors Severe liver impairment (use with caution)
Availability
Letrozole 2.5mg, aromatase inhibitor, breast cancer treatment, hormone therapy, ovulation induction, fertility medication, estrogen blocker, postmenopausal breast cancer